Does Stem Cell Factor Help Activate Dormant Hair Follicles?

Hair growth is not a continuous process. Each hair follicle cycles through phases of growth, regression, rest, and reactivation. Many people experiencing hair thinning or hair loss are not losing follicles permanently; instead, a significant number of follicles become dormant, remaining in a prolonged resting state. This has led researchers to investigate biological signals that may help reactivate these follicles. One signal sometimes mentioned in this context is stem cell factor, often abbreviated as SCF. Understanding how stem cell factor interacts with hair follicles helps clarify both its potential and its limitations in hair regrowth.

Understanding Stem Cell Factor in Simple Terms

Stem cell factor is a naturally occurring protein in the human body. Proteins are molecules that act as messengers, telling cells how to behave. Stem cell factor is best known for its role in blood cell formation, skin pigmentation, fertility, and immune responses. It works by binding to a receptor called c-Kit, which is found on the surface of specific cells. A receptor can be thought of as a lock, while stem cell factor is the key; when the key fits into the lock, it activates a series of internal signals inside the cell.

In the skin, stem cell factor is produced mainly by keratinocytes and fibroblasts. Keratinocytes are the main cells forming the outer layer of the skin, while fibroblasts are support cells that produce structural proteins such as collagen. Hair follicles sit within this environment, meaning they are constantly exposed to signals like stem cell factor.

The Hair Follicle as a Living Mini-Organ

A hair follicle is not a passive structure. It is a complex mini-organ with its own stem cell populations, blood supply, immune interactions, and signaling systems. Hair growth depends on a balance between activating and inhibiting signals. When this balance is disrupted, follicles may enter a prolonged resting phase known as telogen.

At the base of the follicle lies the dermal papilla, a cluster of specialized cells that acts as a command center for hair growth. Surrounding this structure are epithelial stem cells located in an area called the bulge. These stem cells are responsible for regenerating the hair shaft when growth begins again. In human scalp follicles, the dermal papilla is a source of stem cell factor, and its receptor c-Kit is found mainly on pigment-producing cells (melanocytes) (Randall et al. 2008). Whether stem cell factor decides if a follicle stays dormant or re-enters growth has not been shown.

How Stem Cell Factor Interacts with Dormant Follicles

Stem cell factor acts through the c-Kit receptor. When stem cell factor binds to the c-Kit receptor, it triggers internal cellular pathways such as the PI3K/AKT pathway and the MAPK pathway. These pathways regulate cell survival, energy use, and division. In simple terms, they send a message to cells that conditions are favorable for activity and regeneration.

In dormant follicles, cellular activity is low. We found no verified study showing that stem cell factor increases dermal papilla cell survival or moves a resting follicle back into the growth phase, known as the anagen phase. In one human study, c-Kit levels were the same in balding and non-balding follicles, and dermal papilla cells grown from balding scalp released less stem cell factor in the lab. The authors linked this to the paler colour of thinning hairs, not to follicle dormancy (Randall et al. 2008).

Evidence from Laboratory and Animal Research

Most of the evidence on stem cell factor in hair comes from laboratory and animal studies, and it concerns hair colour. In mice, SCF/c-Kit signalling is needed for hair colour (Botchkareva et al. 2001). In that study, blocking c-Kit with an antibody during a hair cycle produced grey or white hairs, which grew back fully pigmented in the next cycle, and mice that made extra stem cell factor in the follicle had more pigment cells. The study measured pigmentation, not the waking of resting follicles. Mouse hair cycles also differ from human hair cycles, making direct translation difficult.

Cell culture studies using human dermal papilla cells have measured how much stem cell factor the cells release (Randall et al. 2008). These experiments provide mechanistic insight, but they do not replicate the full complexity of a living scalp.

We found no published human clinical trial testing stem cell factor as a hair regrowth treatment. Human evidence is indirect, coming from studies of scalp tissue evaluated using immunohistochemistry, a method that stains specific proteins so they can be seen under a microscope.

The lack of large, long-term human trials is a major limitation. Existing studies often involve small populations, short observation periods, and surrogate markers rather than direct hair count measurements. This makes it difficult to draw firm conclusions about how effective stem cell factor modulation might be in common hair loss conditions such as androgenetic alopecia.

Stem Cell Factor and Androgenetic Alopecia

Androgenetic alopecia, commonly known as pattern hair loss, involves hormonal sensitivity, genetic predisposition, inflammation, and altered signaling within the follicle. Stem cell factor does not address all of these factors. Research suggests that while hair follicle stem cells remain present in androgenetic alopecia, their activation signals are weakened. Whether added stem cell factor would help is unknown, and it does not block dihydrotestosterone, the hormone primarily responsible for follicle miniaturization. It has not been tested as a treatment for this condition in controlled human trials.

A critical point often misunderstood is that activating a follicle at the cellular level does not guarantee visible hair regrowth. Hair growth requires sustained signaling, adequate blood flow, structural integrity of the follicle, and absence of chronic inflammation. Stem cell factor contributes to only part of this process. Stem cell factor also activates mast cells and pigment cells. In a small 1996 trial, recombinant human stem cell factor was injected under the skin of 10 patients with advanced breast cancer. Every injection site developed a hive-like (wheal-and-flare) reaction from mast-cell activation, and 5 of the 10 patients developed lasting dark patches at the injection sites (Costa et al. 1996). FDA has approved no stem-cell or exosome product for hair loss (FDA consumer alert, updated 2024).

What Is and Is Not Known

Stem cell factor has a clear role in hair colour in lab and mouse studies. Whether it helps follicles leave the resting phase in people has not been shown, and it is not a proven trigger for hair regrowth. Researchers increasingly emphasize that hair loss is a multifactorial condition. Stem cell factor may be one piece of a much larger biological puzzle, working alongside hormonal regulation, immune balance, mechanical forces, and other growth factors.

Most studies on stem cell factor and hair follicles were conducted between the late 1990s and 2015. Methods include animal models, cell cultures, and observational human studies. Populations range from laboratory mice to isolated human skin cells. Study durations vary widely, from days in cell experiments to months in animal research. Evaluation methods include microscopy, gene expression analysis, protein staining, and visual hair cycle assessment.

Criticism of this body of research centers on limited human data, small sample sizes, lack of standardized outcome measures, and commercial overinterpretation of early findings. These limitations highlight the need for cautious interpretation.

Stem cell factor works by binding to the c-Kit receptor, and in hair follicles this signal is linked mainly to pigment cells and hair colour. It has not been shown to reactivate dormant hair follicles in people, and no controlled human trial has tested it as a hair-loss treatment.

References

Abbas, O., & Mahalingam, M. (2009). Epidermal stem cells: Practical perspectives and potential uses. British Journal of Dermatology, 161(2), 228–236. https://pubmed.ncbi.nlm.nih.gov/19548960/

Botchkareva, N. V., Khlgatian, M., Longley, B. J., Botchkarev, V. A., & Gilchrest, B. A. (2001). SCF/c-Kit signaling is required for cyclic regeneration of the hair pigmentation unit. FASEB Journal, 15(3), 645–658. https://pubmed.ncbi.nlm.nih.gov/11259383/

Costa, J. J., Demetri, G. D., Harrist, T. J., Dvorak, A. M., Hayes, D. F., Merica, E. A., Menchaca, D. M., Gringeri, A. J., Schwartz, L. B., & Galli, S. J. (1996). Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo. Journal of Experimental Medicine, 183(6), 2681–2686. https://pubmed.ncbi.nlm.nih.gov/8676090/

Randall, V. A., Jenner, T. J., Hibberts, N. A., De Oliveira, I. O., & Vafaee, T. (2008). Stem cell factor/c-Kit signalling in normal and androgenetic alopecia hair follicles. Journal of Endocrinology, 197(1), 11–23. https://pubmed.ncbi.nlm.nih.gov/18372228/

Trüeb, R. M. (2002). Molecular mechanisms of androgenetic alopecia. Experimental Gerontology, 37(8–9), 981–990. https://doi.org/10.1016/s0531-5565(02)00093-1

U.S. Food and Drug Administration. (2020, updated 2024). Consumer alert on regenerative medicine products including stem cells and exosomes. https://www.fda.gov/vaccines-blood-biologics/consumers-biologics/consumer-alert-regenerative-medicine-products-including-stem-cells-and-exosomes